Related Experiment Video
Updated: Nov 25, 2025

Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
Recent updates on COVID-19: A holistic review
Shweta Jakhmola1, Omkar Indari1, Dharmendra Kashyap1
1Discipline of Biosciences and Biomedical Engineering, Indian Institute of Technology, Indore, India.
This review covers COVID-19, detailing its origin, SARS-CoV-2 mutations, and transmission. It also explores host pathophysiology, diagnostics, and therapeutics for this global pandemic.
Area of Science:
- Virology
- Epidemiology
- Immunology
Background:
- Coronaviruses, including SARS-CoV-2 causing COVID-19, are RNA viruses linked to significant outbreaks.
- The COVID-19 pandemic, declared by WHO, necessitates comprehensive understanding of the virus and disease.
- SARS-CoV-2 has a zoonotic origin, sharing genetic similarities with bat coronaviruses.
Purpose of the Study:
- To provide a comprehensive overview of COVID-19, encompassing its origin, transmission, and viral mutations.
- To discuss the pathophysiological changes in hosts infected with SARS-CoV-2.
- To review current diagnostics and therapeutic strategies for managing COVID-19.
Main Methods:
- Literature review of scientific articles on coronaviruses and COVID-19.
- Analysis of reported mutations in SARS-CoV-2 key proteins (spike, nucleocapsid, PLpro, ORF3a).
- Examination of the impact of comorbidities on COVID-19 disease outcomes.
Main Results:
- SARS-CoV-2 exhibits significant nucleotide similarity to bat coronaviruses, indicating a zoonotic origin.
- Mutations in viral proteins can affect receptor binding, cell fusion, replication, and assembly.
- Comorbidities like hypertension and diabetes are associated with severe COVID-19 outcomes.
- Current diagnostics include qRT-PCR, CT scans, and serological tests, with repurposed drugs like remdesivir used therapeutically.
Conclusions:
- Understanding SARS-CoV-2 mutations is crucial for assessing virulence and developing targeted therapeutics.
- Comorbidities significantly influence COVID-19 patient prognosis.
- Continued research is vital to accelerate understanding and management of the COVID-19 pandemic.
More Related Videos
Related Concept Videos
Pneumonia III: Complications and Assessment
Pneumonia II: Pathophysiology
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Documentation in Long-Term and Home Healthcare Setting
Long-Term Care Facilities
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

